Delivery Order SPE2DB20D1047-SPE2DB25FF74J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $7,489.37 and an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the awardee's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing indefinite delivery...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector two-packs under a firm fixed price contract with a ceiling value of $3,768.71. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a competitively awarded, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction. This delivery...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 MG auto-injector (2-pack), with a ceiling value of $2,065.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of federal pharmaceutical procurement through AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs under a firm fixed-price contract structure. The order, valued at $15,123.04, will be completed by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet...
- The Defense Logistics Agency awarded a $2,689.26 delivery order to AmerisourceBergen Drug Corp for the procurement of Epinephrine 0.3 mg auto-injector units (2-pack) on July 28, 2025, with completion scheduled for July 29, 2025. This competitively awarded, firm fixed-price contract was issued without set-aside designation to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs (2-pack units) with a ceiling value of $1,504.70 and an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- The Defense Logistics Agency awarded a $5,099.81 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with performance completing by July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,987.16 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF74JDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $1,631.68. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support for military healthcare programs, enabling the contractor to supply a broad range of medications, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen's consistent performance as a federal pharmaceutical vendor demonstrates its capability to meet critical medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/28/25 |